Development and characterization of polyclonal peptide antibodies for the detection of Yellow fever virus proteins

Journal of Virological Methods

Volumn 222, Issue , 2015, Pages 110-116

  Stock, N K ^a,b,c   Escadafal, C ^a,d   Achazi, K ^a,e   Cisse M ^a,f   Niedrig, M ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^c ECDC   (Sweden)

^d INSTITUT PASTEUR   (France)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f UNIV MONTPELLIER   (France)

Author keywords

Capsid protein; NS1 protein; Peptide antisera; Yellow fever virus

Indexed keywords

ANTISERUM; CAPSID PROTEIN; NONSTRUCTURAL PROTEIN 1; PEPTIDE ANTIBODY; POLYCLONAL ANTIBODY; VIRUS PROTEIN; NS1 PROTEIN, FLAVIVIRUS; PEPTIDE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS; DIAGNOSTIC TEST; IMMUNOFLUORESCENCE TEST; JAPANESE ENCEPHALITIS VIRUS; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TICK BORNE ENCEPHALITIS VIRUS; WEST NILE VIRUS; WESTERN BLOTTING; YELLOW FEVER VIRUS; ANIMAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; FLUORESCENT ANTIBODY TECHNIQUE; GUINEA PIG; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; PROCEDURES; RABBIT; SENSITIVITY AND SPECIFICITY; VERO CELL LINE; VIROLOGY;

DENGUE VIRUS; JAPANESE ENCEPHALITIS VIRUS; MAMMALIA; MIRIDAE; TICK-BORNE ENCEPHALITIS VIRUS; WEST NILE VIRUS; YELLOW FEVER VIRUS;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CAPSID PROTEINS; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; CROSS REACTIONS; DIAGNOSTIC TESTS, ROUTINE; FLUORESCENT ANTIBODY TECHNIQUE; GUINEA PIGS; PEPTIDES; RABBITS; SENSITIVITY AND SPECIFICITY; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS; VIROLOGY; YELLOW FEVER VIRUS;

EID: 84934929298     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2015.06.006     Document Type: Article

References (52)

1. Akey D.L., et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 2014, 343(6173):881-885.
2. Alcon S., et al. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 2002, 40(2):376-381.
3. Bae H.G., et al. Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J. Virol. Methods 2003, 110(2):185-191.
4. Balinsky C.A., et al. Nucleolin interacts with the dengue virus capsid protein and plays a role in formation of infectious virus particles. J. Virol. 2013, 87(24):13094-13106.
5. Bhuvanakantham R., Chong M.K., Ng M.L. Specific interaction of capsid protein and importin-alpha/beta influences West Nile virus production. Biochem. Biophys. Res. Commun. 2009, 389(1):63-69.
6. Bulich R., Aaskov J.G. Nuclear localization of dengue 2 virus core protein detected with monoclonal antibodies. J. Gen. Virol. 1992, 73(Pt 11):2999-3003.
7. Chambers T.J., et al. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990, 44:649-688.
8. Chung K.M., Diamond M.S. Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and mice. J. Med. Virol. 2008, 80(3):547-556.
9. Chung K.M., et al. Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms. J. Virol. 2006, 80(3):1340-1351.
10. Colpitts T.M., et al. Dengue virus capsid protein binds core histones and inhibits nucleosome formation in human liver cells. PLOS ONE 2011, 6(9):pe24365.
11. Diamond M.S., Pierson T.C., Fremont D.H. The structural immunology of antibody protection against West Nile virus. Immunol. Rev. 2008, 225:212-225.
12. Dowd K.A., Pierson T.C. Antibody-mediated neutralization of flaviviruses: a reductionist view. Virology 2011, 411(2):306-315.
13. Drosten C., et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J. Clin. Microbiol. 2002, 40(7):2323-2330.
14. Edeling M.A., Diamond M.S., Fremont D.H. Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(11):4285-4290.
15. Elahi M., et al. High resolution crystal structure of dengue-3 envelope protein domain III suggests possible molecular mechanisms for serospecific antibody recognition. Proteins 2013, 81(6):1090-1095.
16. Escadafal C., et al. Rapid molecular assays for the detection of yellow Fever virus in low-resource settings. PLOS Negl. Trop. Dis. 2014, 8(3):pe2730.
17. Garske T., et al. Yellow fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLOS Med. 2014, 11(5):pe1001638.
18. Gelderblom H.R., et al. Comparative immunoelectron microscopy with monoclonal antibodies on yellow fever virus-infected cells: pre-embedding labelling versus immunocryoultramicrotomy. J. Virol. Methods 1985, 10(3):225-239.
19. Gould E.A., et al. Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J. Gen. Virol. 1986, 67(Pt 3):591-595.
20. Houghton-Trivino N., Montana D., Castellanos J. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. Rev. Salud Publica (Bogota) 2008, 10(2):299-307.
21. Kanai R., et al. Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J. Virol. 2006, 80(22):11000-11008.
22. Kiermayr S., Stiasny K., Heinz F.X. Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E. J. Virol. 2009, 83(17):8482-8491.
23. Krishna V.D., Rangappa M., Satchidanandam V. Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells. J. Virol. 2009, 83(10):4766-4777.
24. Kuno G. Serodiagnosis of flaviviral infections and vaccinations in humans. Adv. Virus Res. 2003, 61:3-65.
25. Kwallah A.O., et al. A real-time reverse transcription loop-mediated isothermal amplification assay for the rapid detection of yellow fever virus. J. Virol. Methods 2013.
26. Li Y.Z., et al. A specific and sensitive antigen capture assay for NS1 protein quantitation in Japanese encephalitis virus infection. J. Virol. Methods 2012, 179(1):8-16.
27. Luca V.C., et al. Crystal structure of the Japanese encephalitis virus envelope protein. J. Virol. 2012, 86(4):2337-2346.
28. Ma L., et al. Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(10):3414-3419.
29. Macdonald J., et al. NS1 protein secretion during the acute phase of West Nile virus infection. J. Virol. 2005, 79(22):13924-13933.
30. Mansfield K.L., et al. Flavivirus-induced antibody cross-reactivity. J. Gen. Virol. 2011, 92(Pt 12):2821-2829.
31. Modrow S., et al. Molekulare virologie. Spektrum 2010.
32. Monath T.P. Yellow fever: an update. Lancet Infect. Dis. 2001, 1(1):11-20.
33. Mori Y., et al. Nuclear localization of Japanese encephalitis virus core protein enhances viral replication. J. Virol. 2005, 79(6):3448-3458.
34. Mukhopadhyay S., Kuhn R.J., Rossmann M.G. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 2005, 3(1):13-22.
35. Muller D.A., Young P.R. The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antiviral Res. 2013, 98(2):192-208.
36. Murray J.M., Aaskov J.G., Wright P.J. Processing of the dengue virus type 2 proteins prM and C-prM. J. Gen. Virol. 1993, 74(Pt 2):175-182.
37. Nayak V., et al. Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J. Virol. 2009, 83(9):4338-4344.
38. Niedrig M., et al. Evaluation of an indirect immunofluorescence assay for detection of immunoglobulin M (IgM) and IgG antibodies against yellow fever virus. Clin. Vaccine Immunol. 2008, 15(2):177-181.
39. Nybakken G.E., et al. Crystal structure of the West Nile virus envelope glycoprotein. J. Virol. 2006, 80(23):11467-11474.
40. Pierson T.C., Diamond M.S. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev. Mol. Med. 2008, 10:pe12.
41. Qiu L.W., et al. Development of an antigen capture immunoassay based on monoclonal antibodies specific for dengue virus serotype 2 nonstructural protein 1 for early and rapid identification of dengue virus serotype 2 infections. Clin. Vaccine Immunol. 2009, 16(1):88-95.
42. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 1938, 27(3):493-497.
43. Schlesinger J.J., Brandriss M.W., Walsh E.E. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J. Immunol. 1985, 135(4):2805-2809.
44. Schlesinger J.J., et al. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J. Virol. 1986, 60(3):1153-1155.
45. Simoes M., et al. Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies. Biologicals 2012, 40(6):399-404.
46. Stock N.K., et al. Biological and phylogenetic characteristics of yellow fever virus lineages from West Africa. J. Virol. 2013, 87(5):2895-2907.
47. Stocks C.E., Lobigs M. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM. J. Virol. 1998, 72(3):2141-2149.
48. Wang S.H., et al. Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus. J. Gen. Virol. 2002, 83(Pt 12):3093-3102.
49. Weidmann M., et al. Improved LNA probe-based assay for the detection of African and South American yellow fever virus strains. J. Clin. Virol. 2010, 48(3):187-192.
50. Westaway E.G., et al. Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus. Virology 1997, 234(1):31-41.
51. WHO Yellow fever fact sheet. Wkly. Epidemiol. Rec. 2010, 85(5):33-36.
52. Young P.R., et al. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J. Clin. Microbiol. 2000, 38(3):1053-1057.